FDA Panel Advances Controversial Billions-value Wellness Trend
WHO:
GQ - The FDA panel included six peptide suppliers, a pharmaceutical executive, and a compounding pharmacist.
Entrepreneur - Marty Zakary was the then FDA head during the hearing.
WHAT:
GQ - The FDA's panel recommended the approval of six peptides that had been previously banned for human use under the Biden administration, including the "Wolverine Stack" composed of BPC-157 and TB-500.
Entrepreneur - Hims, a telehealth company, plans to sell the controversial substances after acquiring a peptide manufacturing facility in 2025.
Fox News - The FDA's Pharmacy Compounding Advisory Committee voted to recommend broader access to certain peptides, which could allow licensed compounding pharmacies to prepare them for valid prescriptions.
GQ - The FDA panel voted to recommend the approval of six out of seven peptides that had been previously banned for human use.
GQ - The approved peptides include BPC-157, TB-500, KPV, MOTS-c, Emideltide, and Semax; only Epitalon was rejected.
GQ - The vote on BPC-157 was narrowly approved with an 8-6 vote.
Entrepreneur - The potential market for peptides could be worth billions in the US.
WHERE:
GQ - The hearings took place at the FDA.
WHEN:
GQ - The FDA panel voted on July 23 and 24 to recommend the approval of the peptides.
WHY:
Fox News - Jim LaValle, a Texas-based clinical pharmacist, emphasized that the advisory committee's vote was only a recommendation and not a final FDA decision, highlighting the need for a transparent, science-driven process for peptide approval.
GQ - The recommendations could open the floodgates for a potential multibillion-dollar peptide industry in the US.
GQ - Concerns were raised by multiple FDA officials about the panel being stacked with industry-connected individuals.
HOW:
Fox News - LaValle noted that the "right model" for peptide access includes qualified clinicians, licensed pharmacies, validated quality testing, and meaningful patient follow-up.
GQ - The FDA added eight new experts to the hearing, increasing the total number of voting individuals to 14.
GQ - Peptides are chains of amino acids that serve as messengers to the body's cells and play roles in hormonal regulation, skin health, and the immune system.
(UPDATED July 28, 2026 18:26 UTC)
The FDA's Pharmacy Compounding Advisory Committee has recommended the approval of six peptides previously banned for human use, including the "Wolverine Stack," which features BPC-157 and TB-500. In a related development, telehealth company Hims plans to sell these controversial substances after acquiring a peptide manufacturing facility in 2025. However, clinical pharmacist Jim LaValle cautioned that this recommendation is not a final FDA decision and stressed the importance of a transparent, science-driven process for peptide approval, emphasizing the need for qualified clinicians and licensed pharmacies to ensure patient safety.
--
(UPDATED July 28, 2026 07:55 UTC)
The FDA panel has voted to recommend the approval of six out of seven peptides that were previously banned for human use, with the approved peptides including BPC-157, TB-500, KPV, MOTS-c, Emideltide, and Semax, while Epitalon was rejected. The vote on BPC-157 was particularly close, passing with an 8-6 tally, and this decision could potentially pave the way for a multibillion-dollar peptide industry in the U.S. However, concerns were raised about the panel's composition, as it included several industry-connected individuals, prompting the FDA to add eight new experts to the hearing.